The global Chimeric Antigen Receptor (CAR) T-Cell Therapy market was valued at 4720 million in 2024 and is projected to reach US$ 31340 million by 2031, at a CAGR of 31.8% during the forecast period.
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The CAR T-cell-based drug market is driven by the growing demand for innovative and targeted cancer therapies. Chimeric Antigen Receptor (CAR) T-cell therapy is a revolutionary approach that involves genetically modifying a patient\"s T cells to recognize and attack cancer cells. The success of CAR T-cell therapies in treating certain types of blood cancers, such as leukemia and lymphoma, has fueled market growth and encouraged research into expanding the application of CAR T-cell therapy to other solid tumor malignancies. However, the market also faces challenges, including the high cost of CAR T-cell therapy and the complexity of the manufacturing process, which may limit patient access. Additionally, the potential for severe side effects and the need for patient selection and management pose regulatory and clinical challenges. To succeed, companies must focus on advancing research, streamlining the production process, collaborating with healthcare providers to improve patient access and support, and addressing safety and efficacy concerns to establish CAR T-cell-based drugs as a transformative treatment option for cancer patients.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chimeric Antigen Receptor (CAR) T-Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Chimeric Antigen Receptor (CAR) T-Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chimeric Antigen Receptor (CAR) T-Cell Therapy. This report contains market size and forecasts of Chimeric Antigen Receptor (CAR) T-Cell Therapy in global, including the following market information:
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy market revenue, 2020-2025, 2026-2031, ($ millions)
Global top five Chimeric Antigen Receptor (CAR) T-Cell Therapy companies in 2024 (%)
Total Market by Segment:
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy market, by Type, 2020-2025, 2026-2031 ($ millions)
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy market segment percentages, by Type, 2024 (%)
CD19-targeted
BCMA-targeted
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy market, by Application, 2020-2025, 2026-2031 ($ millions)
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy market segment percentages, by Application, 2024 (%)
Lymphoma
Multiple Myeloma
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy market, by region and country, 2020-2025, 2026-2031 ($ millions)
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chimeric Antigen Receptor (CAR) T-Cell Therapy revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Chimeric Antigen Receptor (CAR) T-Cell Therapy revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chimeric Antigen Receptor (CAR) T-Cell Therapy, market overview.
Chapter 2: Global Chimeric Antigen Receptor (CAR) T-Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of Chimeric Antigen Receptor (CAR) T-Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chimeric Antigen Receptor (CAR) T-Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Overall Market Size
2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size: 2024 VS 2031
2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, Prospects & Forecasts: 2020-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chimeric Antigen Receptor (CAR) T-Cell Therapy Players in Global Market
3.2 Top Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies Ranked by Revenue
3.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies in Global Market, by Revenue in 2024
3.5 Global Companies Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Type
3.6 Tier 1, Tier 2, and Tier 3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Markets, 2024 & 2031
4.1.2 CD19-targeted
4.1.3 BCMA-targeted
4.2 Segmentation by Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue & Forecasts
4.2.1 Segmentation by Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2026-2031
4.2.3 Segmentation by Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2024 & 2031
5.1.2 Lymphoma
5.1.3 Multiple Myeloma
5.2 Segmentation by Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue & Forecasts
5.2.1 Segmentation by Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2026-2031
5.2.3 Segmentation by Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2020-2031
6 Sights by Region
6.1 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2024 & 2031
6.2 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2020-2025
6.2.2 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2026-2031
6.2.3 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2020-2031
6.3 North America
6.3.1 By Country - North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2020-2031
6.3.2 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.3.3 Canada Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.3.4 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.4 Europe
6.4.1 By Country - Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2020-2031
6.4.2 Germany Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.4.3 France Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.4.4 U.K. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.4.5 Italy Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.4.6 Russia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.4.7 Nordic Countries Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.4.8 Benelux Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.5 Asia
6.5.1 By Region - Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2020-2031
6.5.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.5.3 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.5.4 South Korea Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.5.5 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.5.6 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.6 South America
6.6.1 By Country - South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2020-2031
6.6.2 Brazil Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.6.3 Argentina Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2020-2031
6.7.2 Turkey Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.7.3 Israel Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.7.4 Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
6.7.5 UAE Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2020-2031
7 Companies Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.1.4 Novartis Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2020-2025)
7.1.5 Novartis Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Corporate Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.2.4 Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2020-2025)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Corporate Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.3.4 Bristol-Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2020-2025)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 J & J
7.4.1 J & J Corporate Summary
7.4.2 J & J Business Overview
7.4.3 J & J Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.4.4 J & J Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2020-2025)
7.4.5 J & J Key News & Latest Developments
7.5 JW Therapeutics
7.5.1 JW Therapeutics Corporate Summary
7.5.2 JW Therapeutics Business Overview
7.5.3 JW Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.5.4 JW Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2020-2025)
7.5.5 JW Therapeutics Key News & Latest Developments
7.6 FOSUNKite
7.6.1 FOSUNKite Corporate Summary
7.6.2 FOSUNKite Business Overview
7.6.3 FOSUNKite Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.6.4 FOSUNKite Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2020-2025)
7.6.5 FOSUNKite Key News & Latest Developments
7.7 CARsgen Therapeutics
7.7.1 CARsgen Therapeutics Corporate Summary
7.7.2 CARsgen Therapeutics Business Overview
7.7.3 CARsgen Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.7.4 CARsgen Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2020-2025)
7.7.5 CARsgen Therapeutics Key News & Latest Developments
7.8 Autolus Therapeutics
7.8.1 Autolus Therapeutics Corporate Summary
7.8.2 Autolus Therapeutics Business Overview
7.8.3 Autolus Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.8.4 Autolus Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2020-2025)
7.8.5 Autolus Therapeutics Key News & Latest Developments
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Corporate Summary
7.9.2 Sorrento Therapeutics Business Overview
7.9.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.9.4 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2020-2025)
7.9.5 Sorrento Therapeutics Key News & Latest Developments
7.10 Mustang Bio
7.10.1 Mustang Bio Corporate Summary
7.10.2 Mustang Bio Business Overview
7.10.3 Mustang Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.10.4 Mustang Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2020-2025)
7.10.5 Mustang Bio Key News & Latest Developments
7.11 Bluebird Bio
7.11.1 Bluebird Bio Corporate Summary
7.11.2 Bluebird Bio Business Overview
7.11.3 Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.11.4 Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2020-2025)
7.11.5 Bluebird Bio Key News & Latest Developments
7.12 Cellectis
7.12.1 Cellectis Corporate Summary
7.12.2 Cellectis Business Overview
7.12.3 Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.12.4 Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2020-2025)
7.12.5 Cellectis Key News & Latest Developments
7.13 Allogene Therapeutics
7.13.1 Allogene Therapeutics Corporate Summary
7.13.2 Allogene Therapeutics Business Overview
7.13.3 Allogene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.13.4 Allogene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2020-2025)
7.13.5 Allogene Therapeutics Key News & Latest Developments
7.14 Celyad
7.14.1 Celyad Corporate Summary
7.14.2 Celyad Business Overview
7.14.3 Celyad Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.14.4 Celyad Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2020-2025)
7.14.5 Celyad Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Drivers in Global Market
Table 3. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Global Market
Table 5. Top Chimeric Antigen Receptor (CAR) T-Cell Therapy Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Share by Companies, 2020-2025
Table 8. Global Companies Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Type
Table 9. List of Global Tier 1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type – Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2024 & 2031
Table 12. Segmentation by Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn), 2026-2031
Table 14. Segmentation by Application– Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2024 & 2031
Table 15. Segmentation by Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2026-2031
Table 17. By Region– Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2024 & 2031
Table 18. By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2026-2031
Table 20. By Country - North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2026-2031
Table 22. By Country - Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2026-2031
Table 26. By Country - South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2026-2031
Table 28. By Country - Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2026-2031
Table 30. Novartis Corporate Summary
Table 31. Novartis Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 32. Novartis Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2020-2025)
Table 33. Novartis Key News & Latest Developments
Table 34. Gilead Sciences Corporate Summary
Table 35. Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 36. Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2020-2025)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. Bristol-Myers Squibb Corporate Summary
Table 39. Bristol-Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 40. Bristol-Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2020-2025)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. J & J Corporate Summary
Table 43. J & J Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 44. J & J Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2020-2025)
Table 45. J & J Key News & Latest Developments
Table 46. JW Therapeutics Corporate Summary
Table 47. JW Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 48. JW Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2020-2025)
Table 49. JW Therapeutics Key News & Latest Developments
Table 50. FOSUNKite Corporate Summary
Table 51. FOSUNKite Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 52. FOSUNKite Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2020-2025)
Table 53. FOSUNKite Key News & Latest Developments
Table 54. CARsgen Therapeutics Corporate Summary
Table 55. CARsgen Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 56. CARsgen Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2020-2025)
Table 57. CARsgen Therapeutics Key News & Latest Developments
Table 58. Autolus Therapeutics Corporate Summary
Table 59. Autolus Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 60. Autolus Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2020-2025)
Table 61. Autolus Therapeutics Key News & Latest Developments
Table 62. Sorrento Therapeutics Corporate Summary
Table 63. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 64. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2020-2025)
Table 65. Sorrento Therapeutics Key News & Latest Developments
Table 66. Mustang Bio Corporate Summary
Table 67. Mustang Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 68. Mustang Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2020-2025)
Table 69. Mustang Bio Key News & Latest Developments
Table 70. Bluebird Bio Corporate Summary
Table 71. Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 72. Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2020-2025)
Table 73. Bluebird Bio Key News & Latest Developments
Table 74. Cellectis Corporate Summary
Table 75. Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 76. Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2020-2025)
Table 77. Cellectis Key News & Latest Developments
Table 78. Allogene Therapeutics Corporate Summary
Table 79. Allogene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 80. Allogene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2020-2025)
Table 81. Allogene Therapeutics Key News & Latest Developments
Table 82. Celyad Corporate Summary
Table 83. Celyad Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 84. Celyad Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2020-2025)
Table 85. Celyad Key News & Latest Developments
List of Figures
Figure 1. Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Picture
Figure 2. Chimeric Antigen Receptor (CAR) T-Cell Therapy Segment by Type in 2024
Figure 3. Chimeric Antigen Receptor (CAR) T-Cell Therapy Segment by Application in 2024
Figure 4. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue: 2020-2031 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in 2024
Figure 9. Segmentation by Type – Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2024 & 2031
Figure 10. Segmentation by Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2020-2031
Figure 11. Segmentation by Application – Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2024 & 2031
Figure 12. Segmentation by Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2020-2031
Figure 13. By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2020-2031
Figure 14. By Country - North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2020-2031
Figure 15. United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 16. Canada Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 17. Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 18. By Country - Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2020-2031
Figure 19. Germany Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 20. France Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 21. U.K. Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 22. Italy Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 23. Russia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 24. Nordic Countries Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 25. Benelux Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 26. By Region - Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2020-2031
Figure 27. China Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 28. Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 29. South Korea Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 30. Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 31. India Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 32. By Country - South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2020-2031
Figure 33. Brazil Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 34. Argentina Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 35. By Country - Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2020-2031
Figure 36. Turkey Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 37. Israel Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 38. Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 39. UAE Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2020-2031
Figure 40. Novartis Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Bristol-Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. J & J Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. JW Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. FOSUNKite Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. CARsgen Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Autolus Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Mustang Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Allogene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. Celyad Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
